FindTrial
Sign In

Multi-center clinical research on artificial intelligence for accurate diagnosis and treatment of pancreatic cancer

Multi-center clinical research on artificial intelligence for accurate diagnosis and treatment of pancreatic cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036559
Enrollment
Unknown
Registered
2020-08-24
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

Gold Standard:All patients diagnosed pathologically with pancreatic tumor by surgery or puncture biopsy
Index test:Group&#32
theory&#32
model&#32
of&#32
artificial&#32
intelligence

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients diagnosed pathologically with pancreatic tumor by surgery or puncture biopsy.

Exclusion criteria

Exclusion criteria: nil

Design outcomes

Primary

MeasureTime frame
pathological diagnosis;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactShao Chenghao

Shanghai Changzheng Hospital

shaochenghao_czyy@163.com+86 13801938229

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026